Breast implant associated anaplastic large cell lymphoma: a case report and reconstructive option.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 23751975.
- Also identified by DOI 10.1016/j.bjps.2013.04.049.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Since 1995, the association between Anaplastic Large Cell Lymphoma (ALCL) and breast implant capsules has been of increasing concern. Up to 40 cases have been reported worldwide. The majority of cases favour an indolent course, similar to that of primary cutaneous ALCL, with a 10-year survival rate of greater than 90%. Many recommendations have been made for diagnosis, treatment and adjuvant therapy but the issue of reconstruction post capsulectomy and removal of implants has not yet been addressed. We present a case report and management option.
Medical subject headings
- Breast Implants
- Breast Neoplasms
- Lymphoma, Large-Cell, Anaplastic
- Seroma